October 17, 2024
12:00 pm to 2:00 pm EDT
Registration Required
This webinar represents the culmination of OHRP’s and FDA’s efforts to convene interested parties to examine approaches for measuring Institutional Review Board (IRB) effectiveness in protecting human subjects, as recommended by the Government Accountability Office (GAO) in its 2023 report on IRBs. In this webinar, you will hear from experts in their fields about four key approaches for attempting to measure IRB effectiveness that we learned about during our meetings with a variety of interest-holders: (1) post-approval monitoring to verify compliance with IRB requirements, relevant regulations, and institutional policies, (2) accreditation and peer review; (3) study participant considerations, and (4) the quality of IRB deliberations. After the presentations and a panel discussion, members of the public will have the opportunity to ask questions and provide thoughts on this important topic.